Young Onset Type 2 Diabetes Mellitus: A Review

Akhila Bollam,Priyanka Patlolla,Ramya Balaprabha,Rama Rao
DOI: https://doi.org/10.47583/ijpsrr.2022.v74i01.004
2022-05-22
International Journal of Pharmaceutical Sciences Review and Research
Abstract:Diabetes is an increasing global problem. Youth onset type2 diabetes mellitus is increasing in many countries. Early onset type 2 diabetes is increasingly prevalent with significant impact on individual or healthcare service. The individuals with history of type 2 diabetes, obese and leading sedentary life style, black or minority or ethnic group has higher risk of type 2 diabetes mellitus. Individuals with type 2 diabetes have higher risk of complications. Specific symptoms in young people include growth impairment, unexplained loss of weight and wetting of bed. Obesity, particularly abdominal obesity, PCOS, pubertal age group and intrauterine exposure to hyperglycemia are among the risk factors for development of T2DM in children and adolescents. Symptoms of diabetes and random plasma glucose concentration, or glycated haemoglobin or fasting plasma glucose or 2 h plasma glucose during oral glucose tolerance test may be used for diagnosing diabetes. Initial treatment of youth-beginning sort 2 diabetes should incorporate metformin as well as insulin alone or in combination, in view of the metabolic status of the patient. Initial treatment of youthbeginning sort 2 diabetes should incorporate metformin as well as insulin alone or in combination, in view of the metabolic status of the patient. Early onset type 2 diabetes is more aggressive and has higher complications and comorbidities. Youth onset type 2 diabetes creates large personal and societal burden so adequate educational and psychological support should be given. This review on young onset diabetes mellitus provides knowledge on emerging epidemic.
What problem does this paper attempt to address?